3-cyano-4-(4-tetrahydropyran-phenyl)-p yridin-2-one derivatives

Details for Australian Patent Application No. 2008223796 (hide)

Owner Ortho-McNeil-Janssen Pharmaceuticals, Inc Addex Pharma S.A.

Inventors Trabanco-Suarez, Andres Avelino; CidNunez, Jose Maria; Duvey, Guillaume Albert Jacques; Macdonald, Gregor James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008223796

PCT Pub. Number WO2008/107481

Priority 07116403.2 14.09.07 EP; PCT/ EP2007/052442 15.03.07 EP; 07103654.5 07.03.07 EP

Filing date 7 March 2008

Wipo publication date 12 September 2008

Acceptance publication date 17 March 2011

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/4545 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 October 2009 PCT application entered the National Phase

  PCT publication WO2008/107481 Priority application(s): WO2008/107481

17 March 2011 Application Accepted

  Published as AU-B-2008223796

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008223798-Mesh comprising ECM

2008223795-1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2 -receptor modulators